|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Human alveolar macrophages (AM) and lung tissue macrophages (LTM) have a distinct localization in the cellular environment. We studied their response to direct contact with activated T lymphocytes in terms of the production of interstitial
collagenase (MMP-1), 92-kD gelatinase (MMP-9), and of
TIMP-1, one of the counter-regulatory tissue inhibitors of metalloproteinases. Either AM obtained by bronchoalveolar lavage or LTM obtained by mincing and digestion of lung tissue
were exposed for 48 h to plasma membranes of T lymphocytes previously activated with phorbol myristate acetate and
phytohemagglutinin for 24 h. Membranes of activated T cells strongly induced the production of MMP-1, MMP-9, and
TIMP-1 exclusively in LTM but not in AM, whereas membranes
from unstimulated T cells failed to induce the release of
MMPs. Both populations of mononuclear phagocytes spontaneously released only small amounts of MMPs and TIMP-1.
Similar results were obtained when MMP and TIMP-1 expression was analyzed at pretranslational and biosynthetic levels,
respectively. Blockade experiments with cytokine antagonists
revealed the involvement of T-cell membrane-associated interleukin-1 and tumor necrosis factor-
in MMP production by
LTM upon contact with T cells. These data suggest that the
ability of lung macrophages to produce MMPs after direct
contact with activated T cells is related to the difference in
phenotype of mononuclear phagocytes and cell localization. In addition, these observations indicate that cell-cell contact represents an important biological mechanism in potentiating
the inflammatory response of mononuclear phagocytes in the lungs.
| |
Introduction |
|---|
|
|
|---|
Inflammation of the lung may be triggered, and in some cases perpetuated, by stimuli at the airway epithelial surface. Among immunoinflammatory cells in the airways, resident mononuclear cells and activated T lymphocytes play a major part. Lung mononuclear phagocytes consist of at least three populations, functionally and geographically distinct: dendritic cells, lung tissue macrophages (LTM) located in the interstitium, and alveolar macrophages (AM) located on or near the alveolar surface (1). LTM and AM share several functions: defense against pathogens, ingestion and destruction of potential allergens, clearing of particulates, and presentation of antigens to T cells (2). Several investigators have previously reported the regulated production by AM of interstitial collagenase (MMP-1), stromelysin (MMP-3), 92-kD gelatinase (MMP-9), matrilysin (MMP-7), metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases (TIMP)-1, all of which presumably contribute to the physiologic as well as pathologic remodeling of the extracellular matrix (ECM) (3). To date little is known, however, regarding the ability of LTM to produce matrix metalloproteinases (MMPs) and TIMPs. It has been established that during the process of mononuclear phagocyte differentiation from blood monocytes to AM the profile of MMP and TIMP production varies, an increased expression correlating with a more mature cellular phenotype (6). Indeed, immature promonocytic or monocytic cells contain mostly intracellular serine proteinases and produce MMPs in very small quantities (7).
T lymphocytes, present in small numbers in the normal
lung interstitium and actively recruited during inflammatory processes of the airways, secrete various cytokines
that affect the functions of other infiltrating inflammatory
cells and resident tissue cells. We and others have previously observed that cytokines produced by activated T
cells can modulate the expression of MMPs and TIMP-1 by monocyte/macrophages and fibroblasts (8). In addition to the release of soluble factors, interest has also focused on the potential role of direct cell-cell contact in
mediating biological events. Thus, we reported previously
that direct contact between activated human T lymphocytes and monocytes markedly increased the release of cytokines such as interleukin (IL)-1
and tumor necrosis factor (TNF)-
(11, 12), as well as metalloproteinases MMP-1
and MMP-9 and the protease inhibitor TIMP-1 by the latter cells (13). T-cell subsets seem to have opposite effects
in that T helper (Th) 1 cells preferentially induce IL-1
and
Th2 induce the production of IL-1 receptor antagonist (IL-1Ra) upon cell-cell contact with monocytes (14). In murine
models, activated Th2 lymphocytes trigger signals that induce the activation of interferon (IFN)-
-primed macrophages (15, 16). Stout and coworkers (17) also reported
subsequently that CD40-CD40 ligand interaction is necessary for T-cell activation of macrophages. Likewise, direct
contact between T cells and monocyte/macrophages via
CD40-CD40 ligand mediate, at least in part, the induction of MMPs by mononuclear phagocytes (18).
The potential of direct cell-cell interaction to amplify
and perpetuate the inflammatory process prompted us to
study the influence of activated T lymphocytes on two distinct mononuclear cell populations in the lungs. We found
that T cell-macrophage contact failed to induce AM to increase their production of MMPs or TIMP. In contrast,
when T lymphocytes were in direct contact with LTM,
their expresssion of MMPs and TNF-
was massively induced, and part of the induction was dependent on IL-1
and TNF-
bound to activated T-cell membranes.
| |
Materials and Methods |
|---|
|
|
|---|
Reagents
Phorbol myristate acetate (PMA) was purchased from Sigma
Chemical Co. (St. Louis, MO), dissolved in dimethylsulfoxide
and stored in aliquots of 1 mg/ml at
70°C. Purified phytohemagglutinin (PHA), obtained from E.Y. Laboratories Inc. (San Mateo, CA) and dissolved in phosphate-buffered saline (PBS) free
of Ca2+ and Mg2+, was stored in aliquots of 1 mg/ml at
70°C.
Bovine serum albumin, phenylmethylsulfonyl fluoride, ethylenediaminetetraacetic acid, and Triton X-100 were obtained from
Sigma Chemical Co. RPMI-1640, PBS, fetal calf serum (FCS),
penicillin, streptomycin, and L-glutamine were purchased from
GIBCO BRL (Paisley, UK).
Cell Preparation and Culture
Human AM were obtained from the uninvolved lung tissue of patients undergoing surgical resection for pulmonary carcinoma. Segments or lobes were lavaged and processed as described previously (8). The adherent macrophages were cultured at a concentration of 1 × 106 cells/ml in the presence of RPMI-1640 medium containing 5% FCS, penicillin (100 U/ml), streptomycin (100 ng/ml), and 2 mM L-glutamine in 24-well cluster plates (catalog no. 3524; Costar Corp., Cambridge, MA).
LTM were obtained by proteolytic dispersion of the uninvolved lung tissue of individuals undergoing surgical resection (19). After 24 h of culture under the same conditions as described previously, supernatant was removed and the adherent cells, which represented LTM, were removed from the plate with a rubber policeman, washed three times with PBS, counted, and plated at a concentration of 1 × 106 cells/ml in the conditions described previously. More than 95% of these cells consisted of mature macrophages with their characteristic appearance being revealed by May-Grünwald-Giemsa and inverted macroscopy. Most contaminating cells such as fibroblasts, lymphocytes, and neutrophils were removed by three washes the day before and three further washes the day they were removed from plates by gentle scraping.
AM were obtained from peripheral lung tissue that was unaffected by lung carcinoma. Although most of our patients were current smokers, 30% of the patients were nonsmokers or former smokers. As far as the latter are concerned, no significant changes in the response of AM or LTM were found.
Preparation of Membranes from Human Peripheral Blood T Lymphocytes and T-cell Lines
T lymphocytes from human peripheral blood (PBTL) were harvested from the buffy coat of healthy donors and processed as previously described (11). The T cells obtained were stimulated, their membranes isolated and stored as described (11).
Membranes were prepared from the HUT 78 T-cell line, a human cutaneous T-cell lymphoma line (American Type Culture Collection, Rockville, MD), by the method of Aderem and colleagues
(20). Briefly, HUT 78 cells were incubated at 1 × 106 cells/ml in medium with or without PMA (5 ng/ml) and PHA (1 µg/ml) for 24 h.
The cells were then processed as described previously (13). The final membrane preparation obtained was resuspended at 50 × 106
cells/ml of RPMI medium and frozen at
70°C until later use.
Culture of AM and LTM with T-Cell Membranes
AM or LTM were dispensed onto 24-well culture plates at 1 × 106
cells/well in 1 ml of medium. Afterwards, the membranes from the
unstimulated membrane of T cells (Tumb) or stimulated membranes of T cells (Tsmb) were resuspended in culture medium and
added to mononuclear cells to obtain a final ratio equivalent to
eight T lymphocytes per one mononuclear cell in each well, a ratio
found to be optimal for cocultures in previous studies (11, 13). Controls consisted of medium alone or PMA (5 ng/ml). After 48 h
of incubation at 37°C, the conditioned media were collected and
stored at
20°C until further analysis. For blockade experiments, IL-1Ra was added to lung macrophages (AM or LTM) in culture
medium for 30 min at 37°C, while T cell membranes or HUT 78 cells were incubated with TNF binding protein (TNF-bp) or medium alone for 30 min at 4°C. Preincubated membranes were then
added to preincubated macrophages for 48 h so that neither membranes nor macrophages were washed before culture.
MMP and TIMP-1 Determination
Samples of conditioned media were subjected to enzyme-linked immunosorbent assay (ELISA) for the determination of MMP-1, MMP-9, and TIMP-1 as described previously (5, 21, 22). The sensitivity for all protein assays was 10 ng/ml.
Flow Cytometric Analysis
The following antibodies were used for cytometry: anti-CD14 (clone MY4) was purchased from Coulter Clone (Hialeah, FL), anti-human leukocyte-associated antigen-DR (HLA-DR) from Dako A/F (Glostrup, Denmark), anti-B7.1 (CD80) (clone L307.4) from Becton-Dickinson (San Jose, CA), anti-B7.2 (CD86) (clone IT2.2) from Pharmingen (San Diego, CA), anti-CD40 (clone MAB89) and control mouse immunoglobulin (Ig)G were obtained from Immunotech (Marseille, France). The expression of surface antigens by LTM and AM was compared. After isolation of the macrophages as described previously, cells were incubated with the different monoclonal antibodies for 45 min at 4°C. Cells were stained by using a fluorescein isothiocyanate (FITC) isotype-specific goat antimouse IgG (Immunotech). The samples were analyzed on a FACScan (Coulter, EPICS XL-MCL; Becton-Dickinson). Dead cells were gated out based on their light scatter properties. Results are expressed in mean ± standard error of the mean (SEM).
Cytokine Inhibitors
Human recombinant IL-1Ra was a gift from Dr. R. C. Thompson
(Synergen, Boulder, CO) and pegylated soluble tumor necrosis
factor receptor type I (PEG sTNF-R1), also named pegylated
TNF binding protein (PEG TNFbp), a gift from Dr. C. Edwards
III (Amgen, Boulder, CO). LTM and AM were incubated in 96 wells/plate with medium alone or IL-1Ra for 30 min at 37°C.
Meanwhile, unstimulated or stimulated PBTL or HUT 78 cells
were preincubated with medium alone or TNF-bp for 30 min on
ice before their addition to the macrophages. After 48 h of culture, supernatants were collected and analyzed for their contents
in MMP-9 and TIMP-1. Final concentrations of IL-1Ra and TNF-bp were 1 µg/ml and 10
8 M, respectively.
Metabolic Labeling and Immunoprecipitation Studies
All samples subjected to immunoprecipitation were conditioned
for 24 h in the presence of [35S]methionine. To study T-cell effects, mononuclear cells were exposed to Tumb or Tsmb at the ratio described previously or to PMA (5 ng/ml) for a period of 48 h
in RPMI-1640 culture medium. Media were then replaced with
fresh media free of methionine but containing [35S]methionine
for 24 h (8). For immunoprecipitation, polyclonal antisera to human MMP-1, MMP-7, MMP-9, and TIMP-1 were used as reported previously (21, 22). Processed samples were applied to
12% polyacrylamide slab gels and electrophoresis was performed (23). The gels were exposed to Hyperfilm (CEA AB; Amersham, Solna, Sweden) for 24 to 48 h at
70°C.
RNA Preparation and Northern Blot Hybridization
Total cellular RNA from 1 × 107 LTM or AM, cultured with Tumb,
HUT-78umb, Tsmb, HUT-78smb, or PMA, was extracted by the
guanidine isothiocyanate method and purified by cesium chloride
density gradient centrifugation (24). Total RNA (5 µg) was processed for Northern blot analysis as described previously (13).
Membranes were sequentially hybridized at 42°C overnight with
32P-labeled complementary DNA (cDNA) probes for MMP-1 (25),
MMP-9 (8), and TIMP-1 (kindly provided by D. Carmichael,
Synergen, Boulder, CO). glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA, provided by R. Pierce (Washington
University School of Medicine, St. Louis, MO), was used as control probe. Filters were then exposed to Hyperfilm for 24 to 48 h
at
70°C.
By using a densitometer equipped with ImageQuant software (Molecular Dynamics, Sunnyvale, CA), autoradiographs were scanned and quantified, and values were normalized to GAPDH values.
| |
Results |
|---|
|
|
|---|
Difference in Response of LTM and AM to Direct Cell-Cell Contact with Activated T Lymphocytes
Under basal conditions, LTM and AM released small but
quantifiable amounts of MMP-1, MMP-9, TIMP-1, and
TNF-
(Table 1). Values are the results of four different experiments involving four individuals, LTM and AM being
derived from the same individual in each experiment from
whom the PBTL were obtained. Contact between LTM and
Tumb for 48 h did not result in a significant change in the
basal production of MMP-1, MMP-9, and TIMP-1 (1.2-fold,
1.3-fold, and 1.6-fold, respectively). However, TNF-
was
significantly induced 34-fold (Table 1,
P < 0.01), but when
LTM were cultured in the presence of Tsmb, a marked increase in production of MMP-1, MMP-9, TIMP-1, and
TNF-
was observed (5-fold, 3.5-fold, 2.7-fold, and 250-fold,
respectively). In the presence of AM, Tumb yielded a moderate release of MMP-9 (2.2-fold), TIMP-1 (3.8-fold; Table
1, *P < 0.05), and TNF-
(20-fold; Table 1,
P < 0.01) but
failed to affect the production of MMP-1. The moderate increase in MMP-9 and TIMP-1 on AM could be due to the
effect of phagocytosis of the membranes by macrophages or
to stimulating molecules present at low levels in unstimulated cells. In contrast to LTM, AM exposed to Tsmb
showed no significant stimulation of MMP or TIMP-1 expression (1.5-fold for MMP-1, 2.7-fold for MMP-9, and 2.7-fold for TIMP-1, respectively) compared with cells incubated with Tumb (see P values in Table 1). Nevertheless,
TNF-
production was strongly induced (100-fold) in AM
cultured with Tsmb as compared with Tumb.
|
Time Course of MMP-9 and TIMP-1 Production by LTM versus AM in Response to T-Cell Membranes
To determine to what extent the duration of contact between Tumb and LTM or AM affected the induction of MMPs and TIMP-1, macrophages were exposed to T-cell membranes (Tmb) for various periods of time. LTM in contact with Tsmb released significant amounts of MMP-9 after 48 h (Figure 1A). The release of TIMP-1 also took place 48 h after contact with Tsmb (Figure 1B). As shown previously (Table 1), AM contrary to LTM failed to exhibit any increased production of MMP-9 (Figure 1C) or TIMP-1 (Figure 1D) at any time point examined, whether in the presence of Tumb or Tsmb. The occasional reduction below levels is also seen with Tumb. Kinetics of MMP-1 production were analyzed in only one experiment of three performed due to the small number of cells available. The production of MMP-1 was markedly increased when LTM were in contact with Tsmb compared with Tumb, but the enzyme was undetectable in media from AM in contact with either unstimulated or stimulated T cells (data not shown).
|
Effect of Tmb Concentrations on the Capacity to Induce MMP-9 and TIMP-1 in LTM versus AM
Production of MMP-9 and TIMP-1 by each LTM and AM was determined in the presence of increasing amounts of Tumb or Tsmb. Tmb were added to mononuclear cells for 48 h, yielding a final ratio equivalent to 2, 4, 8, and 16 T lymphocytes per 1 mononuclear cell/well. Consistent with results shown in Table 1 and Figure 1, LTM production of MMP-9 and TIMP-1 was markedly stimulated by Tsmb (Figures 2A and 2B). Whereas the expression of MMP-9 was optimal when using Tsmb in amounts equivalent to eight T cells per one LTM (Figure 2A), the stimulation of TIMP-1 required lesser amounts of Tsmb, the magnitude of response being somewhat attenuated by higher concentrations of Tsmb (Figure 2B). In contrast to LTM, AM did not respond to Tsmb at whatever concentration in terms of MMP-9 or TIMP-1 production (Figures 2C and 2D). These findings are further proof of the dichotomous response of LTM and AM to Tsmb versus Tumb exposure. Kinetics of MMP-1 production were not analyzed because of the small number of cells available and the low levels of produced enzyme.
|
Modulation by Tmb of De Novo Synthesis of MMPs and TIMP-1 in LTM but not AM
To gain insight into the intracellular processes governing the production of MMPs and TIMP-1 during cell contact with Tmb, LTM or AM were metabolically labeled with [35S]methionine. Labeled proteins were immunoprecipitated with antisera specific for MMP-1, MMP-9, MMP-7, and TIMP-1. Data on MMP-7 (matrilysin) were obtained only by this method because ELISA was not available. Tsmb stimulated LTM for the biosynthesis of MMP-1, MMP-9, and MMP-7 as well as TIMP-1 (Figure 3A). Tumb were only slightly stimulatory. In contrast, when AM were tested for de novo protein synthesis, production of MMP-1, MMP-9, and MMP-7 was not stimulated to a greater extent by Tsmb than by Tumb (Figure 3B). PMA was used as positive control in these experiments. It is noteworthy that in this experiment, addition of Tsmb to AM actually tended to decrease the synthesis of TIMP-1 as compared with Tumb (Figure 3B). This observation was confirmed in another similar experiment, and this phenomenon will be the subject of further studies. Taken as a whole, these data largely mirror protein release in culture supernatants (Table 1).
|
Pretranslational Control of Macrophage Expression of MMP-9 and TIMP-1 after Contact with Tmb
To further assess at which level T cells exert control on phagocytic cells, Northern blot analysis was performed. LTM and AM were cultured for 24 h in the presence of Tumb, Tsmb, or PMA before harvesting total RNA. Both LTM and AM expressed basal messenger RNA (mRNA) levels of MMP-1, MMP-9, and TIMP-1 (Figure 4), and addition of Tumb slightly stimulated the expression of MMP and TIMP-1 mRNA. However, after exposure to Tsmb, both MMP and TIMP-1 mRNA were increased in LTM while remaining partly unmodified in AM, when compared with the effect of Tumb. PMA used as positive control does not stimulate MMP and TIMP-1 expression in AM. Another experiment was performed and confirmed that on LTM, PMA stimulates both MMP-1 and MMP-9 mRNA expression while slightly decreasing TIMP-1 mRNA levels on AM (data not shown). Once again, neither PMA, Tsmb, or Tumb stimulated markedly MMP-9 expression in AM. These data confirm those obtained previously for protein secretion and protein biosynthesis, and indicate that the regulatory effects induced on LTM by Tsmb occur at a pretranslational level.
|
Analysis of Cell-Surface Molecules on Macrophages
Because LTM and AM are macrophages obtained from two locations in the lung tissue, we analyzed their expression of cell-surface molecules in order to define phenotypic differences between these two macrophage populations. After isolation of both cell types as described in MATERIALS AND METHODS, cells were incubated with various markers, revealed with FITC-conjugated antibody, and fluorescence-activated cell sorter analysis was performed. Among the various cell-surface molecules studied, only the expression of human leukocyte-associated antigen-DR (HLA-DR) molecules appears to be significantly different in LTM and AM (Table 2). In Figure 5, the small difference in mean fluorescence intensity (delta means) for CD14, CD40, CD80, or CD86 on AM or LTM compared with controls is in the same order of magnitude as the SEM of the mean fluorescence of the controls (Table 2) with the exception of HLA-DR, where delta means are increased by several orders of magnitude. These data suggest that both LTM and AM have many phenotypic characteristics in common and that the only difference demonstrated so far is their surface expression of HLA-DR molecules, which could be consistent with a better function as antigen-presenting cells for LTM.
|
|
Involvement of Cell-Surface-Associated Cytokines on Contact Between T Cells and Lung Macrophages
To assess the role of T-cell membrane-bound cytokines in
the induction of MMPs during T cell-macrophage contact,
specific inhibitors of IL-1 and TNF-
were used. Tmb (Tu
and Ts) and lung macrophages (AM and LTM) were exposed to TNF-bp and IL-1Ra, respectively, before coincubation. From Figure 6, it is evident that on contact with
membrane from stimulated PBTL (Figure 6A), the production of MMP-9 by LTM is markedly decreased by the
addition of TNF-bp (44% of inhibition), whereas this cytokine had no effect on the level of MMP-9 produced by
LTM in contact with stimulated HUT 78 cells (Figure 6B).
When used alone, IL-1Ra did not show any significant inhibitory effect but added to TNF-bp, the inhibition of
MMP-9 was marked upon contact with stimulated PBTL
and HUT 78 cells (60 and 66%, respectively). Of note,
TNFbp added to IL-1Ra exerted an inhibitory effect on
MMP-9 production due to unstimulated T cells (60% of
inhibition on LTM + PBTL contact, and 58% on LTM + HUT 78 cell contact) (Figures 6A and 6B). However,
TNF-bp alone only had an inhibitory effect on LTM + HUT 78 cell contact (28%), but very little on LTM + PBTL contact (6%). As pointed out in this report, stimulated T cells have no effect on the production of MMP-9
by AM, making it difficult to analyze the potential inhibitory effect of TNF-bp or IL-1Ra (Figures 6C and 6D).
When TNF-bp or TNF-bp and IL-1Ra were added to AM,
the production of MMP-9 decreased by 25 to 45% in all
culture conditions. However, as concentration of MMP-9
is low (< 100 ng/ml), small variations could also be due to
the decreased sensitivity of the ELISA at such low values. Both cytokine inhibitors do not have any effect on the production of TIMP-1 during PBTL-LTM contact or T cell-
AM contact. Only when added to HUT 78 cells was TNF-bp able to inhibit 25% of the production of TIMP-1 by
LTM (data not shown). Moreover, when TNF-
production was measured by ELISA in this blockade experiment, IL-1Ra alone or added to TNF-bp did not decrease the
production of TNF-
in LTM, whereas IL-1Ra alone or
added to TNF-bp had a strong inhibitory effect (95%) on
the production of TNF-
by AM (data not shown). These
data suggest that LTM and AM use different signaling
pathways to produce cytokines when in contact with activated T cells.
|
| |
Discussion |
|---|
|
|
|---|
This study demonstrates that the direct contact between T
lymphocytes and lung macrophages may play a major part
in the pathogenesis of lung inflammation by mediating the
induction of both proinflammatory cytokines and MMPs.
Among several potential T-cell surface factors involved in
the stimulation of lung macrophages, both membrane- associated IL-1 and TNF-
are potent triggers of the stimulation observed upon cell-cell contact. Direct contact was
studied by using plasma membrane preparations of T cells
to avoid contamination of cytosolic or intracellular molecules due to leakage. The striking observation is the existence of a fundamental difference in the capacity of macrophages originating from interstitial tissue versus alveolar
space to produce MMPs on contact with activated T cells, presumably reflecting a distinct pattern of responsiveness
and biological significance. Only LTM are stimulated by
membranes of activated T cells to express MMPs. Thus,
LTM may play a pivotal role in tissue remodeling because
they can mediate tissue destruction directly by secreting
their own MMPs or indirectly by releasing cytokines such
as TNF-
that in turn induce the production of MMPs by
fibroblasts in the vicinity (26, 27).
In contrast, AM, which are located mostly in the alveolar spaces of the lung, do not secrete more MMPs after direct contact with activated T cells than with nonactivated
T cells; however, TNF-
is increased in these conditions.
Of importance, on comparing the effects of Tsmb and
Tumb, the production of MMP-1, MMP-9, TIMP-1, and
TNF-
was significantly increased on LTM, whereas on
AM only TNF-
was increased. This suggests that AM
play a more important role in maintaining the inflammatory state rather than in directing the destructive and remodeling process when in direct contact with activated T
cells. Even if phenotypic analysis with the reagents used
did not reveal any difference between these two cell populations, the differential responses in MMP production of
LTM and AM emphasize that these are two distinct functional types of lung macrophages whose variant states of
differentiation could result in specific patterns of responsiveness and biological behavior (6).
As AM have previously been shown to produce MMPs
and inhibitors through the action of various stimuli (6),
it seems reasonable to postulate that the difference in the
capacity of the two cell populations to respond to T cells
lies mainly in the manner in which they interact with T
cells. In previous reports, we (8) and others (9, 10) demonstrated that AM are able to respond to soluble products
expressed by T cells (i.e., soluble cytokines), whereas in
the present study we show that AM are not able to produce MMPs and TIMP-1 when stimulated by direct T-cell
contact. The decrease in TIMP-1 expression by stimulated
T cells on AM has not been observed on other monocytic
cells (13). According to a recent report published by our
group (28), the expression of TIMP-1 by dermal fibroblasts or synoviocytes varies depending on the time of
T-cell stimulation. This suggests that T cells stimulated for
short periods of time (1 to 4 h) are able to induce the production of TIMP-1 in fibroblasts or synoviocytes, whereas T cells stimulated for long periods of time (24 to 48 h) lose the capacity to modify TIMP-1 production. These effects
are probably due to the distinct modifications in the expression of surface factors depending on the time of stimulation. Because T cells were stimulated for long periods of
time (48 h) in our study, they probably lost the capacity to
modify TIMP-1 production by AM, which is in keeping
with the report by Burger and coworkers (28). Owing to
the difficulty in obtaining sufficient amounts of cells from
human sources we were not able to perform rigorous time
course experiments. In the past (11), we observed that T lymphocytes stimulate monocytes through the action of
multiple cell-surface factors: these studies revealed that
the IL-1
production by the monocytic cell line THP-1
was partially inhibited by antibodies to CD11b and to
CD11c (59 and 50% inhibition, respectively) (11) and by
antibodies to CD69 (33% inhibition) (12; data not shown). Interestingly, in the same experiments, none of these antibodies was able to inhibit the production of MMP by T
cell-activated THP-1 cells. The presence of cell-associated
cytokines, such as TNF-
(29) or IL-1 (30), has been described and may represent important stimulatory signals.
TNF-
expressed on membranes of activated T cells has
been shown to induce production of IL-10 by monocytes
(31) or the expression of integrins and cytokines by endothelial cells (32). Moreover, detectable levels of membrane-associated IL-1
and TNF-
have been measured
on membrane preparation of PHA/PMA-activated PBTL
(28). Recently, two of our reports (28, 33) have pointed
out that those cell-associated cytokines play a major part
during T cell and fibroblast interaction. The first report
suggests that the production of MMP-1 and prostaglandin E2 by synoviocytes or fibroblasts during direct contact
with T cells is mainly dependent on membrane-associated
TNF-
and IL-1
(28). In contrast, during T-cell and
monocyte interaction, neither the antagonist to TNF nor
that to IL-1 had significant effects (12, 33). According to
the previous report (28), the association of IFN-
, TNF-
,
and IL-1 on membranes of T cells results in the potent inhibition of collagen I production by fibroblasts (34). We
also analyzed the involvement of membrane-associated
TNF-
and IL-1 on activation of macrophages during interaction with T cells. The blockade of TNF-
, particularly
in association with IL-1Ra inhibitor, decreased by > 50%
the production of MMP-9 by LTM, without specific activity on AM. However, as the inhibition is not complete, unknown cell-surface factors
not characterized yet
may
be required for T cells to stimulate the production of MMPs by mononuclear phagocytes. A possibility not to be
ruled out is that some of the inhibitory effects of cytokine
antagonists may not exclusively be due to the effect on
membrane-associated cytokines but also on cytokines produced in an autocrine fashion by macrophages. However,
this possibility does not seem too likely because in the
presence of Tsmb, TNF-
is produced to an equal extent
by AM and LTM (Table 1). Others observed in a murine
model that soluble products of T lymphocytes (i.e., IFN-
)
are important for macrophage activation (35), and TNF-
or CD40 ligand expressed on T-cell membrane contact
contributes to stimulating macrophage functions upon direct
cell-cell (15, 35).
Thus, the important role in mediating contact response
of certain receptors and their ligand, as well as membrane-associated cytokines, may explain the differential behavior
of LTM and AM when in direct contact with T cells. We
suggest that LTM have cell-surface glycoproteins capable
of interacting with the glycoproteins of activated T cells,
whereas AM do not express such cell-surface glycoproteins, responsible for MMP induction. Other studies have shown that as a result of biological maturation, AM, contrary to their precursor monocytes and LTM, tend to cease
to express several surface markers (36). Like other markers, CD14 is considerably reduced or altogether absent on
normal AM, unlike monocytes (36). Contrary to normal
AM, which express little or no CD80 (B7-1), CD86 (B7-2),
or CD40, AM of patients with active sarcoidosis do, as do
mature dendritic cells (37). LTM did not differ significantly from AM with regard to these markers, except for
the expression of HLA-DR; thus, with the latter exception, they do not express molecules
present on mature
dendritic cells
that are likely to interact with T cells. It is,
however, possible that other glycoproteins are present on
LTM, which may explain why the response of LTM and
AM, when in contact with Tumb or Tsmb, was not identical.
To ascertain the viability of AM and their potential to
be activated, each experiment was performed in the presence of PMA, known to induce cytokine and MMP production on macrophages. We consistently observed that
PMA stimulated, at various levels, the expression of
MMPs and TIMP-1 by AM (Figures 3 and 4), contrary to
Tsmb cells, which were unable to induce such a response.
Further demonstration of AM viability was their capacity
for full induction of TNF-
expression in the presence of
stimulated T cells. Moreover, most of our observations are
based on HUT 78 T-cell lines, used as a substitute for lymphocytes derived from peripheral blood or tissue-resident
lymphocytes. Because previous studies have confirmed
that in direct contact with monocytes or dermal fibroblasts, T cells or T-cell clones have similar biological functions to those of T-cell lines (13, 28, 33), we postulate
that the latter have similar biological effects on lung macrophages. So far, we have performed two experiments
with freshly isolated peripheral blood T lymphocytes confirming their similar biological effect on lung macrophages
(Figure 6).
ECM degradation, which occurs during tissue remodeling in inflammatory processes, is tightly regulated, matrix remodeling being mediated largely by secreted proteins of the MMP and TIMP families. The finding that direct cell-to-cell contact between activated T cells and mononuclear phagocytes induces MMPs, which facilitate matrix breakdown, may be highly relevant to the understanding of immunopathologic processes. The key finding regarding the functional aspect of differential mature macrophage phenotypes is novel and of clinical importance. The biological significance can be that cell-cell interaction is of greater relevance at the tissue level than in the extracellular space (i.e., alveolar space). Moreover, the capacity of restricted, specific populations of lung macrophages to participate in certain aspects of these responses may start to explain the diversity of the underlying pathobiology of lung inflammation, injury, and repair. Interfering in a specific manner at the level of the direct contact between T cells and distinct subsets of mononuclear phagocytes may be a useful addition to the therapeutic arsenal.
| |
Footnotes |
|---|
Address correspondence to: Jean-Michel Dayer, M.D., Division of Immunology and Allergy, University Hospital, 24, rue Micheli-du-Crest, 1211 Geneva 14, Switzerland. E-mail: Jean-Michel.Dayer{at}hcuge.ch
(Received in original form November 2, 1999 and in revised form November 2, 2000).
Abbreviations: alveolar macrophages, AM; complementary DNA, cDNA; enzyme-linked immunosorbent assay, ELISA; fluorescein isothiocyanate, FITC; glyceraldehyde-3-phosphate dehydrogenase, GAPDH; human leukocyte-associated antigen-DR, HLA-DR; immunoglobulin, Ig; interleukin, IL; interleukin-1 receptor antagonist, IL1RA; lung tissue macrophages, LTM; matrix metalloproteinase, MMP; interstitial collagenase, MMP-1; 92-kD gelatinase, MMP-9; matrilysin, MMP-7; messenger RNA, mRNA; peripheral blood T lymphocytes, PBTL; phosphate-buffered saline, PBS; phytohemagglutinin, PHA; phorbol myristate acetate, PMA; standard error of the mean, SEM; T helper, Th; tissue inhibitor of metalloproteinases, TIMP; T-cell membranes, Tmb; tumor necrosis factor, TNF; stimulated membranes of T cells, Tsmb; unstimulated membranes of T cells, Tumb.Acknowledgments: The authors thank Fadia El Habre and Marie-Thérèse Kaufmann for excellent technical assistance. This study was supported by grants 31-33786-92 (J.-M.D.), 31-50930-97 (J.-M.D.), and 32-53002-97 (L.P.N.) from the Swiss National Science Foundation, by grant HL-29594 (H.G.W.) from the National Institutes of Health, and by grant 3524 from the Council for Tobacco Research (H.G.W.).
| |
References |
|---|
|
|
|---|
1. Hance, A. J., S. Douches, R. J. Winchester, V. J. Ferrans, and R. Cristal. 1985. Characterization of mononuclear phagocyte subpopulation in the human lung using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis. J. Immunol. 134: 284-292 [Abstract].
2. Brain, J. D.. 1988. Lung macrophages: how many kinds are there? What do they do? Am. Rev. Respir. Dis. 137: 507-509 [Medline].
3.
Welgus, H. G.,
C. J. Fliszar,
J. L. Seltzer,
T. M. Schmid, and
J. J. Jeffrey.
1990.
Differential susceptibility of type X collagen to cleavage by two
mammalian interstitial collagenases and 72 kDa type IV collagenase.
J.
Biol. Chem.
265:
13521-13527
4.
Shapiro, S. D.,
D. K. Kobayashi, and
T. J. Ley.
1993.
Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages.
J. Biol. Chem.
268:
23824-23829
5.
Busiek, D. F.,
F. P. Ross,
S. McDonnell,
G. Murphy,
L. M. Matrisian, and
H. G. Welgus.
1992.
The matrix metalloprotease matrilysin (PUMP) is expressed in developing human mononuclear phagocytes.
J. Biol. Chem.
267:
9087-9092
6. Shapiro, S. D., E. J. Campbell, R. M. Senior, and H. G. Welgus. 1991. Proteinases secreted by human mononuclear phagocytes. J. Rheumatol. Suppl 18:95-98.
7.
Hanson, R. D.,
N. L. Connolly,
D. Burnett,
E. J. Campbell,
R. M. Senior, and
T. J. Ley.
1990.
Developmental regulation of the human cathepsin G
gene in myelomonocytic cells.
J. Biol. Chem.
265:
1524-1530
8. Lacraz, S., L. P. Nicod, B. Galve-de Rochemonteix, C. Baumberger, J.-M. Dayer, and H. G. Welgus. 1992. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by IL-4. J. Clin. Invest. 90: 382-388 .
9.
Shapiro, S. D.,
E. J. Campbell,
D. K. Kobayashi, and
H. G. Welgus.
1990.
Immune modulation of metalloproteinase production in human macrophages: selective pretranslational suppression of interstitial collagenase
and stromelysin biosynthesis by interferon-
.
J. Clin. Invest.
86:
1204-1210
.
10.
Lotz, M., and
P.-A. Guerne.
1991.
Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA).
J. Biol. Chem.
266:
2017-2020
11.
Vey, E.,
J.-H. Zhang, and
J.-M. Dayer.
1992.
IFN-
and 1,25(OH2)D3 induce on THP-1 cells distinct patterns of cell surface antigen expression, cytokine production, and responsiveness to contact with activated T cells.
J.
Immunol.
149:
2040-2046
[Abstract].
12.
Isler, P.,
E. Vey,
J.-H. Zhang, and
J.-M. Dayer.
1993.
Cell surface glycoproteins expressed on activated human T cells induce production of interleukin-1
by monocytic cells: a possible role of CD69.
Eur. Cytokine Netw.
4:
15-23
[Medline].
13.
Lacraz, S.,
P. Isler,
E. Vey,
H. G. Welgus, and
J.-M. Dayer.
1994.
Direct
contact between T-lymphocytes and monocytes is a major pathway for the
induction of metalloproteinase expression.
J. Biol. Chem.
269:
22027-22033
14.
Chizzolini, C.,
R. Chicheportiche,
D. Burger, and
J.-M. Dayer.
1997.
Human Th1 cells preferentially induce interleukin (IL)-1
while Th2 cells induce IL-1 receptor antagonist production upon cell/cell contact with
monocytes.
Eur. J. Immunol.
27:
171-177
[Medline].
15. Stout, R. D., and J. Suttles. 1993. T cell-macrophage cognate interaction in the activation of macrophage effector function by Th2 cells. J. Immunol. 150: 5330-5337 [Abstract].
16. Tao, X., and R. D. Stout. 1993. T cell-mediated cognate signaling of nitric oxide production by macrophages: requirements for macrophage activation by plasma membranes isolated from T cells. Eur. J. Immunol. 23: 2916-2921 [Medline].
17. Stout, R. D., J. Suttles, J. C. Xu, I. S. Grewal, and R. A. Flavell. 1996. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J. Immunol. 156: 8-11 [Abstract].
18. Malik, N., B. W. Greenfield, A. F. Wahl, and P. A. Kiener. 1996. Activation of human monocytes through CD40 induces matrix metalloproteinases. J. Immunol. 156: 3952-3960 [Abstract].
19. Nicod, L. P., M. F. Lipscomb, G. B. Toews, and J. C. Weissler. 1989. Separation of potent and poorly functional human lung accessory cells based on autofluorescence. J. Leukoc. Biol. 45: 458-465 [Abstract].
20.
Aderem, A. A.,
M. M. Keum,
E. Pure, and
Z. A. Cohn.
1986.
Bacterial lipopolysaccharides, phorbol myristate acetate, and zymosan induce the
myristoylation of specific macrophage proteins.
Proc. Natl. Acad. Sci. USA
83:
5817-5821
21. Bergmann, U., J. Michaelis, R. Oberhoff, V. Knäuper, R. Beckmann, and H. Tschesche. 1989. Enzyme-linked immunosorbent assays for the quantitative determination of human leukocyte collagenase and gelatinase. J. Clin. Chem. Clin. Biochem. 27: 351-359 [Medline].
22.
Welgus, H. G., and
G. P. Stricklin.
1983.
Human skin fibroblast collagenase
inhibitor: comparative studies in human connective tissues, serum, and
amniotic fluid.
J. Biol. Chem.
258:
12259-12264
23. King, J., and U. K. Laemmli. 1971. Polypeptides of the tail fibres of bacteriophage T4. J. Mol. Biol. 62: 465-477 [Medline].
24. Chirgwin, J. M., A. E. Prybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299 [Medline].
25.
Goldberg, G. I.,
S. M. Wilhelm,
A. Kroneberger,
E. A. Bauer,
G. A. Grant, and
A. Z. Eisen.
1986.
Human fibroblast collagenase: complete primary
structure and homology to an oncogene transformation-induced rat protein.
J. Biol. Chem.
261:
6600-6605
26.
Dayer, J.-M.,
B. Beutler, and
A. Cerami.
1985.
Cachectin/tumor necrosis
factor stimulates collagenase and prostaglandin E2 production by human
synovial cells and dermal fibroblasts.
J. Exp. Med.
162:
2163-2168
27. Dayer, J.-M., B. de Rochemonteix, B. Burrus, S. Demczuk, and C. A. Dinarello. 1986. Human recombinant interleukin-1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J. Clin. Invest. 77: 645-648 .
28. Burger, D., R. Rezzonico, J. M. Li, C. Modoux, R. A. Pierce, H. G. Welgus, and J.-M. Dayer. 1998. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes. Arthritis Rheum. 41: 1748-1759 [Medline].
29.
Liu, C. C.,
P. A. Detmers,
S. B. Jiang, and
J. D. Young.
1989.
Identification
and characterization of a membrane-bound cytotoxin of murine cytolytic
lymphocytes that is related to tumor necrosis factor/cachectin.
Proc. Natl.
Acad. Sci. USA
86:
3286-3290
30. Kurt-Jones, E. A., W. Fiers, and J. S. Prober. 1987. Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts. J. Immunol. 139: 2317-2324 [Abstract].
31.
Parry, S. L.,
M. Sebbag,
M. Feldmann, and
F. M. Brennan.
1997.
Contact
with T cells modulates monocyte IL-10 production: role of T cell membrane TNF
.
J. Immunol.
158:
3673-3681
[Abstract].
32. Lou, J., J.-M. Dayer, G. E. Grau, and D. Burger. 1996. Direct cell/cell contact with stimulated T lymphocytes induces the expression of cell adhesion molecules and cytokines by human brain microvascular endothelial cells. Eur. J. Immunol. 26: 3107-3113 [Medline].
33. Burger, D., and J.-M. Dayer. 1998. Interactions between T cell plasma membranes and monocytes. In T Cells in Arthritis. P. Miossec, W. B. van den Berg, and G. S. Firestein, editors. Birkhäuser, Basel. 111-128.
34.
Rezzonico, R., and
J.-M. Dayer.
1998.
Direct contact between T lymphocytes and human dermal fibroblasts or synoviocytes down-regulates type I
and III collagen production via cell-associated cytokines.
J. Biol. Chem.
273:
18720-18728
35. Stout, R. D.. 1993. Macrophage activation by T cells: cognate and non-cognate signals. Curr. Opin. Immunol. 5: 398-403 [Medline].
36. Nicod, L.P., F. El, and Habre. 1992. Adhesion molecules on human lung dendritic cells and their role for T-cell activation. Am. J. Respir. Cell Mol. Biol. 7: 207-213 .
37.
Nicod, L. P., and
P. Isler.
1997.
Alveolar macrophages in sarcoidosis coexpress high levels of CD86 (B7.2), CD40, and CD30L.
Am. J. Respir. Cell
Mol. Biol.
17:
91-96
This article has been cited by other articles:
![]() |
N. L. Webster and S. M. Crowe Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases J. Leukoc. Biol., November 1, 2006; 80(5): 1052 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chen, A. S. Farivar, M. S. Mulligan, and D. K. Madtes Tissue Inhibitor of Metalloproteinase-1 Deficiency Abrogates Obliterative Airway Disease after Heterotopic Tracheal Transplantation Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 464 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Acuff, K. J. Carter, B. Fingleton, D. L. Gorden, and L. M. Matrisian Matrix Metalloproteinase-9 from Bone Marrow-Derived Cells Contributes to Survival but not Growth of Tumor Cells in the Lung Microenvironment Cancer Res., January 1, 2006; 66(1): 259 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Burger, N. Molnarfi, L. Gruaz, and J.-M. Dayer Differential Induction of IL-1{beta} and TNF by CD40 Ligand or Cellular Contact with Stimulated T Cells Depends on the Maturation Stage of Human Monocytes J. Immunol., July 15, 2004; 173(2): 1292 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
J-M. Dayer How T-lymphocytes are activated and become activators by cell{-}cell interaction Eur. Respir. J., September 20, 2003; 22(44_suppl): 10s - 15s. [Full Text] [PDF] |
||||
![]() |
M. M. Monick, R. K. Mallampalli, A. B. Carter, D. M. Flaherty, D. McCoy, P. K. Robeff, M. W. Peterson, and G. W. Hunninghake Ceramide Regulates Lipopolysaccharide-Induced Phosphatidylinositol 3-Kinase and Akt Activity in Human Alveolar Macrophages J. Immunol., November 15, 2001; 167(10): 5977 - 5985. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |